T2 Biosystems, Inc. Appoints Dr. Joanne Spadoro to Serve as Chief Operations Officer, Effective No Later Than September 6, 2016
July 07, 2016 at 04:20 pm EDT
Share
On July 6, 2016, the Board of Directors of T2 Biosystems, Inc. appointed Dr. Joanne Spadoro, Ph. D., to serve as the Company’s Chief Operations Officer, effective upon the date she commences employment with the Company, but no later than September 6, 2016. Prior to joining the Company, Dr. Spadoro was at Immucor from 2010 to March, 2016, her most recent positions being Chief Scientific Officer and Vice President of Worldwide Operations.
T2 Biosystems, Inc. is an in vitro diagnostics company focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. Its technology enables detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its focus includes three areas: sepsis, bioterrorism, and Lyme disease. The Company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the T2 Magnetic Resonance (T2MR) technology. It also has an active pipeline of products, including the United States T2Resistance Panel, the Candida auris test, and the T2Lyme Panel. T2Dx Instrument is a fully automated instrument that is capable of running a range of diagnostic tests from patient samples.
T2 BIOSYSTEMS, INC. 
